pharmaceutical-investing Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA
pharmaceutical-investing Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Merck Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for MK-1293, an Investigational Follow-On Biologic Insulin Glargine
Shire Reports Record Full-year Revenue and Strong Double Digit Growth in Non GAAP Diluted Earnings per ADS
Eagle Energy Metals Corp. and Spring Valley Acquisition Corp. II Announce Effectiveness of Registration Statement and Record and Meeting Dates for Extraordinary General Meeting of Shareholders to Approve Proposed Business Combination
